サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1126931

タンパク質療法の世界市場規模、シェア、産業動向分析レポート：製品別、用途別、地域別展望および予測、2022年～2028年

Global Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By Product, By Application, By Regional Outlook and Forecast, 2022 - 2028
出版日: | 発行: KBV Research | ページ情報: 英文 235 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
タンパク質療法の世界市場規模、シェア、産業動向分析レポート：製品別、用途別、地域別展望および予測、2022年～2028年
出版日: 2022年08月31日
発行: KBV Research
ページ情報: 英文 235 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

タンパク質療法の世界市場規模は、予測期間中にCAGR6.9%の市場成長率で上昇し、2028年には4,902億米ドルに達すると予測されています。

特定の条件下で欠損している、あるいは不足しているタンパク質は、治療用タンパク質で置き換えることができます。また、病気や化学療法の影響を軽減するために、体内で有用なタンパク質の産生を増やすことも可能です。遺伝子工学によって生産されたタンパク質は、置き換えようとする天然タンパク質に酷似している場合もあれば、改良されている場合もあります。

COVID-19の影響分析

COVID-19のパンデミックは、世界中の経済に深刻な打撃を与えました。多くの企業が突然のパンデミックの出現によって著しく破壊されました。さらに、いくつかの製造および生産施設は、自国内の様々な政府によって課されたロックダウンのために、発生のために閉鎖されました。タンパク質療法市場もまた、パンデミックの初期に混乱に陥りました。ロックダウンにより、重要な医療用品の開発や配送に大きな遅れが生じました。このため、治療用タンパク質の生産に支障が生じました。

市場の成長要因

世界の癌患者の増加

タンパク質療法市場の成長を促す主な要因の1つは、世界中でさまざまな種類のがんが蔓延していることです。身体のあらゆる部位に影響を及ぼす可能性のある病気は、すべてがんと呼ばれます。新生物や悪性腫瘍は、この疾患を示すために使用される他の言葉です。がんの特徴の一つは、異常な細胞が素早く発生し、正常な境界線から外れて拡大し、他の体の構成要素に浸潤し、最終的には他の臓器に移動することです。これが「転移」です。がん患者さんが亡くなる主な理由は、体内の転移が広範囲に及んでいるためです。

政府・規制当局による承認プロセス加速への注目度上昇

先進国だけでなく発展途上国でも、珍しい病気や複雑な病気に苦しむ多くの人々が、生命を守るために必要な薬として、日々血漿由来の治療薬に頼っています。特に免疫グロブリンは、世界的に見てもそのニーズは大きく、現在も増え続けています。血漿由来製剤とは、ヒトの血漿を分画することにより、血漿中の適切なタンパク質を分離した製剤のことです。血液中の最大の成分は血漿と呼ばれ、タンパク質、塩類、酵素、水から構成されています。原発性および二次性免疫不全症、出血性疾患、インヒビター欠乏症、その他の希少疾患は、すべて血漿由来の医薬品で治療されています。

市場抑制要因

高い製造コストと管理コスト

タンパク質療法市場の成長における大きな課題は、タンパク質療法のコストの高さです。製品価格が高いため、患者の早期完全回復に必要な治療法の一部が利用できなくなっています。いくつかの国では、価格はさらに法律で管理されています。医薬品を消費者に販売するコストの大部分を負担することができる国のヘルスケア組織に対する権限を通じて、政府機関はコストを制限しているのです。

製品の展望

製品別では、タンパク質療法市場は、モノクローナル抗体、インスリン、融合タンパク質、エリスロポエチン、インターフェロン、ヒト成長ホルモン、毛包刺激ホルモンに区分されます。2021年、インスリンセグメントはタンパク質療法市場で大きな収益シェアを獲得しました。このセグメントの成長の上昇は、主に世界中で糖尿病の症例が増加していることに起因しています。インスリンは、膵臓で産生される天然ホルモンです。このホルモンの生産不足は、人体の糖尿病レベルを刺激する要因となっています。

アプリケーションの展望

タンパク質療法市場は、用途別に、代謝性疾患、免疫性疾患、血液疾患、がん、ホルモン性疾患、遺伝性疾患、その他に分類されます。2021年、代謝疾患セグメントは、タンパク質療法市場の最大の収益シェアを調達しました。このセグメントの成長の上昇は、病気、特に糖尿病の治療のための高品質の薬と適応性のある治療法に対する急激な需要によるもので、このセグメントの成長をサポートすると予想されます。

地域別の展望

地域別に見ると、タンパク質療法市場は北米、欧州、アジア太平洋、LAMEAで分析されています。2021年、北米はタンパク質療法市場で最大の収益シェアを占めました。これは、慢性疾患の発生率の増加、最先端の治療法の使用、重要なプレイヤーの存在、同地域の医療費の増加などに起因しています。さらに、北米の国々は、いくつかの新しい技術やアプローチをいち早く採用しています。

市場参加者がとる主な戦略は買収です。Cardinalマトリックスで提示された分析によると、ジョンソン＆ジョンソンとファイザーがタンパク質療法市場の前身です。メルク・アンド・カンパニー、インコーポレイテッド、アムジェン、イーライリリーなどの企業があります。Amgen, Inc.、Eli Lilly and Companyなどの企業が、タンパク質療法市場における主要な革新者の一人です。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場規模
  • セグメンテーション
    • タンパク質療法の世界市場、製品別
    • タンパク質療法の世界市場、用途別
    • タンパク質療法の世界市場、地域別
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要の説明
      • 市場の構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場の抑制要因

第3章 競合分析-世界

  • KBVカーディナルマトリックス
  • 最近の業界全体の戦略的展開
    • パートナーシップ、コラボレーション、契約
    • 製品上市と製品拡張
    • 買収と合併
    • 製品上市と製品拡大
  • 主要成功戦略
    • 主要なリーディング戦略：パーセンテージ分布（2018-2022）
    • 主要な戦略的動き：（買収と合併：2018年、3月～2022年、6月）主要なプレーヤーたち

第4章 タンパク質療法の世界市場：製品別

  • モノクローナル抗体の世界市場：地域別
  • ヒト成長ホルモンの世界市場：地域別
  • 融合タンパク質の世界市場：地域別
  • インスリンの世界市場：地域別
  • エリスロポエチンの世界市場：地域別
  • インターフェロンの世界市場：地域別
  • 卵胞刺激ホルモンの世界市場：地域別

第5章 タンパク質療法の世界市場：用途別

  • 代謝異常の世界市場：地域別
  • 免疫系疾患の世界市場：地域別
  • 血液疾患の世界市場：地域別
  • 癌の世界市場：地域別
  • ホルモン障害の世界市場：地域別
  • 遺伝性疾患の世界市場：地域別
  • 地域別の世界のその他市場

第6章 タンパク質療法の世界市場：地域別

  • 北米
    • 北米のタンパク質療法国別市場
      • 米国
      • カナダ
      • メキシコ
      • 北米の残りの地域
  • 欧州
    • 欧州のタンパク質療法の国別市場
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域のタンパク質療法市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • LAMEA
    • LAMEAのタンパク質療法市場：国別
      • ブラジル
      • アルゼンチン
      • UAE
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他のLAMEA

第7章 企業プロファイル

  • Abbott Laboratories
  • Baxter International, Inc.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly And Company
  • Merck & Co., Inc.
  • Johnson & Johnson（Janssen Global Services, LLC）
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.
図表

LIST OF TABLES

  • TABLE 1 Global Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 2 Global Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Protein Therapeutics Market
  • TABLE 4 Product Launches And Product Expansions- Protein Therapeutics Market
  • TABLE 5 Acquisition and Mergers- Protein Therapeutics Market
  • TABLE 6 Trial and Approvals- Protein Therapeutics Market
  • TABLE 7 Global Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 8 Global Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 9 Global Monoclonal Antibodies Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Monoclonal Antibodies Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Human Growth Hormone Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Human Growth Hormone Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Fusion Protein Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Fusion Protein Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Insulin Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Insulin Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Erythropoietin Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Erythropoietin Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Interferon Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Interferon Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Follicle Stimulating Hormone Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Follicle Stimulating Hormone Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 24 Global Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 25 Global Metabolic Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Metabolic Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Immunologic Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Immunologic Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Hematological Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Hematological Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Cancer Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Cancer Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Hormonal Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Hormonal Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 35 Global Genetic Disorders Market by Region, 2018 - 2021, USD Million
  • TABLE 36 Global Genetic Disorders Market by Region, 2022 - 2028, USD Million
  • TABLE 37 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 38 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 39 Global Protein Therapeutics Market by Region, 2018 - 2021, USD Million
  • TABLE 40 Global Protein Therapeutics Market by Region, 2022 - 2028, USD Million
  • TABLE 41 North America Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 42 North America Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 43 North America Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 44 North America Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 45 North America Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Human Growth Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Human Growth Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Fusion Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Fusion Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Insulin Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Insulin Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Interferon Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Interferon Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 60 North America Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 61 North America Metabolic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Metabolic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Immunologic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Immunologic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Hematological Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 66 North America Hematological Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 67 North America Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 69 North America Hormonal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 70 North America Hormonal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 71 North America Genetic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 72 North America Genetic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 73 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 74 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 75 North America Protein Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 76 North America Protein Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 77 US Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 78 US Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 79 US Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 80 US Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 81 US Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 82 US Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 83 Canada Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 84 Canada Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 85 Canada Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 86 Canada Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 87 Canada Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 88 Canada Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 89 Mexico Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 90 Mexico Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 91 Mexico Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 92 Mexico Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 93 Mexico Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 94 Mexico Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 95 Rest of North America Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 96 Rest of North America Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 97 Rest of North America Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 98 Rest of North America Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 99 Rest of North America Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 100 Rest of North America Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 101 Europe Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 102 Europe Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 103 Europe Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 104 Europe Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 105 Europe Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Human Growth Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Human Growth Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Fusion Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Fusion Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Insulin Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Insulin Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Interferon Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Interferon Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Europe Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 120 Europe Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 121 Europe Metabolic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Metabolic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Europe Immunologic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 124 Europe Immunologic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 125 Europe Hematological Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 126 Europe Hematological Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 127 Europe Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Europe Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Europe Hormonal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Europe Hormonal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Europe Genetic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Europe Genetic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Europe Protein Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 136 Europe Protein Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 137 Germany Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 138 Germany Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 139 Germany Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 140 Germany Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 141 Germany Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 142 Germany Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 143 UK Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 144 UK Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 145 UK Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 146 UK Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 147 UK Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 148 UK Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 149 France Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 150 France Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 151 France Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 152 France Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 153 France Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 154 France Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 155 Russia Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 156 Russia Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 157 Russia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 158 Russia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 159 Russia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 160 Russia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 161 Spain Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 162 Spain Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 163 Spain Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 164 Spain Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 165 Spain Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 166 Spain Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 167 Italy Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 168 Italy Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 169 Italy Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 170 Italy Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 171 Italy Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 172 Italy Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 173 Rest of Europe Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 174 Rest of Europe Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 175 Rest of Europe Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 176 Rest of Europe Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 177 Rest of Europe Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 178 Rest of Europe Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Human Growth Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Human Growth Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Fusion Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Fusion Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Insulin Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Insulin Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Interferon Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Interferon Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Metabolic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Metabolic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Immunologic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Immunologic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Hematological Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Hematological Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Hormonal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Hormonal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Asia Pacific Genetic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 210 Asia Pacific Genetic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 211 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 212 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 213 Asia Pacific Protein Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 214 Asia Pacific Protein Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 215 China Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 216 China Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 217 China Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 218 China Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 219 China Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 220 China Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 221 Japan Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 222 Japan Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 223 Japan Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 224 Japan Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 225 Japan Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 226 Japan Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 227 India Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 228 India Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 229 India Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 230 India Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 231 India Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 232 India Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 233 South Korea Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 234 South Korea Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 235 South Korea Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 236 South Korea Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 237 South Korea Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 238 South Korea Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 239 Singapore Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 240 Singapore Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 241 Singapore Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 242 Singapore Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 243 Singapore Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 244 Singapore Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 245 Malaysia Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 246 Malaysia Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 247 Malaysia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 248 Malaysia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 249 Malaysia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 250 Malaysia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 251 Rest of Asia Pacific Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 252 Rest of Asia Pacific Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 253 Rest of Asia Pacific Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 254 Rest of Asia Pacific Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 255 Rest of Asia Pacific Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 256 Rest of Asia Pacific Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Human Growth Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Human Growth Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Fusion Protein Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Fusion Protein Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Insulin Market by Country, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Insulin Market by Country, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Erythropoietin Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Erythropoietin Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Interferon Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Interferon Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Metabolic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Metabolic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Immunologic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Immunologic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Hematological Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Hematological Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Hormonal Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Hormonal Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA Genetic Disorders Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA Genetic Disorders Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Protein Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Protein Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 293 Brazil Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 294 Brazil Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 295 Brazil Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 296 Brazil Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 297 Brazil Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 298 Brazil Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 299 Argentina Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 300 Argentina Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 301 Argentina Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 302 Argentina Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 303 Argentina Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 304 Argentina Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 305 UAE Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 306 UAE Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 307 UAE Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 308 UAE Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 309 UAE Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 310 UAE Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 311 Saudi Arabia Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 312 Saudi Arabia Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 313 Saudi Arabia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 314 Saudi Arabia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 315 Saudi Arabia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 316 Saudi Arabia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 317 South Africa Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 318 South Africa Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 319 South Africa Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 320 South Africa Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 321 South Africa Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 322 South Africa Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 323 Nigeria Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 324 Nigeria Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 325 Nigeria Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 326 Nigeria Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 327 Nigeria Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 328 Nigeria Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 329 Rest of LAMEA Protein Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 330 Rest of LAMEA Protein Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 331 Rest of LAMEA Protein Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 332 Rest of LAMEA Protein Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 333 Rest of LAMEA Protein Therapeutics Market by Application, 2018 - 2021, USD Million
  • TABLE 334 Rest of LAMEA Protein Therapeutics Market by Application, 2022 - 2028, USD Million
  • TABLE 335 Key Information - Abbott Laboratories
  • TABLE 336 Key Information - Baxter International, Inc.
  • TABLE 337 Key Information - Amgen, Inc.
  • TABLE 338 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 339 Key Information - Eli Lilly And Company
  • TABLE 340 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 341 Key information -Johnson & Johnson
  • TABLE 342 Key Information - Pfizer, Inc.
  • TABLE 343 Key information - Novo Nordisk A/S
  • TABLE 344 Key Information - Sanofi S.A.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
  • FIG 4 Key Strategic Move: (Acquisition and Mergers: 2018, Mar - 2022, Jun) Leading Players
  • FIG 5 Global Protein Therapeutics Market Share by Product, 2021
  • FIG 6 Global Protein Therapeutics Market Share by Product, 2028
  • FIG 7 Global Protein Therapeutics Market by Product, 2018 - 2028, USD Million
  • FIG 8 Global Protein Therapeutics Market Share by Application, 2021
  • FIG 9 Global Protein Therapeutics Market Share by Application, 2028
  • FIG 10 Global Protein Therapeutics Market by Application, 2018 - 2028, USD Million
  • FIG 11 Global Protein Therapeutics Market Share by Region, 2021
  • FIG 12 Global Protein Therapeutics Market Share by Region, 2028
  • FIG 13 Global Protein Therapeutics Market by Region, 2018 - 2028, USD Million
  • FIG 14 Swot analysis: Abbott laboratories
  • FIG 15 Recent strategies and developments: Merck & Co., Inc.
目次

The Global Protein Therapeutics Market size is expected to reach $490.2 billion by 2028, rising at a market growth of 6.9% CAGR during the forecast period.

Protein therapeutic medicines are a class of pharmaceuticals used to treat a range of illnesses, including cancer, metabolic, hematological, immunological, hormonal, genetic, contagious diseases, and others. These medications could greatly enhance human health. Protein distribution in appropriate amounts to the body to enable the precise functioning of various glands, as well as other organs in the body, is the basic concept behind protein therapy, which is conceptually related to gene therapy.

Genetically modified versions of naturally produced human proteins are called therapeutic proteins. They can be utilized to swap out proteins that are defective or lacking in a particular condition. They can also increase the supply of a helpful protein, which helps lessen the effects of chemotherapy or sickness. The proteins produced by genetic engineering can be made to closely match the natural proteins they are meant to replace, or they can be improved by the addition of sugars and other compounds that prolong the protein's activity.

A protein that is defective or lacking in a certain condition can be replaced with therapeutic proteins. They can also increase the body's production of a helpful protein to lessen the effects of illness or chemotherapy. The proteins produced by genetic engineering may closely resemble the natural proteins they are intended to replace, or they may be improved.

Covid-19 Impact Analysis

The COVID-19 pandemic severely hampered the economy all over the world. A number of businesses were significantly demolished by the abrupt emergence of the pandemic. Moreover, several manufacturing and production facilities were closed owing to the outbreak due to the lockdown imposed by various governments within their countries. The protein therapeutics market was also disrupted in the initial period of the pandemic. Lockdown caused major delays within the development and delivery of crucial medical supplies. Attributed to this, the production of therapeutic protein was impeded.

Market Growth Factors

An increase in the cases of cancer across the world

One of the major factors that are driving the growth of the protein therapeutics market is the expansion in the prevalence of various types of cancer all over the world. Any disease that can affect any region of the body is referred to as cancer. Neoplasms and malignant tumors are other words that are used to denote this disease. One characteristic of cancer is the quick development of aberrant cells that expand outside of their normal borders, infiltrate other body components, and eventually move to other organs. This process is known as metastasis. The main reason why cancer patients die is because of widespread metastases within their bodies.

Rising focus of governments and regulatory bodies in accelerating the process of approval for this practice

A significant number of people in various developed, as well as developing nations who suffer from uncommon and complex diseases, depend on plasma-derived therapies every day as essential, life-saving medications. The need for these treatments, in particular immunoglobulins, has grown significantly and is still growing on a global scale. Plasma-derived therapies are treatments made from human plasma through a fractionation procedure in which the pertinent plasma proteins are isolated. The single largest component of human blood is called plasma, which is made up of proteins, salts, enzymes, and water. Primary and secondary immunodeficiencies, bleeding disorders, inhibitor deficiencies, and other rare diseases are all treated with plasma-derived medicines.

Market Restraining Factors

High manufacturing and administration cost

A major challenge in the growth of the protein therapeutics market is the high cost of protein therapies. Because of high product prices, some therapies that patients need for a speedy and complete recovery are no longer available. In several nations, prices are additionally governed by law. Through their authority over national healthcare organizations, which can cover a significant portion of the cost of distributing drugs to consumers, government bodies restrict costs.

Product Outlook

On the basis of Product, the Protein Therapeutics Market is segmented into Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone. In 2021, the Insulin segment garnered a significant revenue share of the protein therapeutics market. The rise in the growth of the segment is majorly attributed to the increasing cases of diabetes all over the world. Insulin is a natural hormone, which is produced by the pancreas. The lack of production of this hormone is the factor that stimulates the diabetes level of the human body.

Application Outlook

By application, the Protein Therapeutics Market is segregated into Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others. In 2021, the metabolic disorders segment procured the biggest revenue share of the protein therapeutics market. The rise in the growth of the segment is due to the exponential demand for high-quality medications and adaptable therapies for the treatment of diseases, particularly diabetes, which is anticipated to support the segment's growth.

Regional Outlook

Region-wise, the Protein Therapeutics Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America held the largest revenue share of the protein therapeutics market. This is ascribed to an increase in the incidence of chronic diseases, the use of cutting-edge treatments, the presence of important players, and an increase in healthcare spending in the area. Moreover, North American countries are early adopters of several new technologies and approaches.

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson and Pfizer, Inc. are the forerunners in the Protein Therapeutics Market. Companies such as Merck & Co., Inc. Amgen, Inc., Eli Lilly and Company are some of the key innovators in Protein Therapeutics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Pfizer, Inc., Novo Nordisk A/S and Sanofi S.A.

Recent Strategies Deployed in Protein Therapeutics Market

Partnership, Collaboration and Agreements:

Aug-2022: Merck came into a collaboration with Orna Therapeutics, a biotechnology company. Following this collaboration, the companies would work on the discovery, development, and commercialization of multiple programs, encompassing therapeutics and vaccines in the sector of infectious disease and oncology.

Mar-2022: Novo Nordisk joined hands with Massachusetts Institutes of Technology and Brigham and Women's Hospital. Through this collaboration, the company aimed to leverage the distinct prospect to bring new transformational solutions to patients by utilizing its distinct capabilities.

Jan-2022: Amgen teamed up with Amgen Generate Biomedicines, a therapeutics company. Under this collaboration, the companies aimed to develop and manufacture protein therapeutics to address 5 clinical ailments.

Jan-2022: Merck teamed up with Absci, the drug, and target discovery company. Following this collaboration, Merck aimed to leverage Absci's platform to utilize its compelling opportunity intending to develop new biologic candidates as well as explore complex protein expression.

Aug-2021: Eli Lilly and Company joined hands with Lycia Therapeutics, a biotechnology company. Following this collaboration, the companies aimed to focus on the development, manufacturing, and marketing of new targeted therapeutics leveraging the proprietary lysosomal targeting chimera protein degradation technology of Lycia.

Sep-2020: Merck collaborated with Seattle Genetics, an American biotechnology company. With this collaboration, the companies aimed to further expand the oncology portfolio of Merck in order to enhance the lives of cancer patients.

Acquisition and Mergers:

Jun-2022: Pfizer took over ReViral, a privately held, clinical-stage biopharmaceutical company. Through this acquisition, the company aimed to integrate RSV investigational treatments of ReViral into its portfolio in order to acquire an offering of promising therapeutic candidates.

Nov-2021: Pfizer took over Trillium Therapeutics, a clinical-stage immuno-oncology company. This acquisition aimed to offer an impressive portfolio, including biologics, to Pfizer

Jul-2021: Amgen took over Teneobio, a clinical-stage biotechnology company. With this acquisition, the company aimed to leverage Teneobio's antibody platform in order to complement its prevailing capabilities. Moreover, the company also aimed to gain a diverse range of building blocks that can be created into new multispecific therapeutics.

Jul-2021: Eli Lilly and Company completed its acquisition of Protomer, a pre-clinical stage biotechnology company. Under this acquisition, the company aimed to help Protomer in enhancing its diabetes range with its innovative technology.

Feb-2021: Merck took over VelosBio, a privately held clinical-stage biopharmaceutical company. Through this acquisition, the company aimed to boost its expanding oncology portfolio while also strengthening its long-term growth potential.

Aug-2020: Johnson & Johnson completed its acquisition of Momenta Pharmaceuticals, a biotechnology company. This acquisition aimed to strengthen Janssen's position in the autoimmune diseases sector and offer a major catalyst for sustained growth of the company.

Approvals and Trials:

Sep-2020: Baxter International received the US FDA approval for its Clinimix and Clinimix E. The new formulations aimed to complement the offerings of medical formulations with their higher protein content.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Monoclonal Antibodies
  • Human Growth Hormone
  • Fusion Protein
  • Insulin
  • Erythropoietin
  • Interferon
  • Follicle Stimulating Hormone

By Application

  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Baxter International, Inc.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly And Company
  • Merck & Co., Inc.
  • Johnson & Johnson (Janssen Global Services, LLC)
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Protein Therapeutics Market, by Product
    • 1.4.2 Global Protein Therapeutics Market, by Application
    • 1.4.3 Global Protein Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Product Launches and Product Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Acquisition and Mergers: 2018, Mar - 2022, Jun) Leading Players

Chapter 4. Global Protein Therapeutics Market by Product

  • 4.1 Global Monoclonal Antibodies Market by Region
  • 4.2 Global Human Growth Hormone Market by Region
  • 4.3 Global Fusion Protein Market by Region
  • 4.4 Global Insulin Market by Region
  • 4.5 Global Erythropoietin Market by Region
  • 4.6 Global Interferon Market by Region
  • 4.7 Global Follicle Stimulating Hormone Market by Region

Chapter 5. Global Protein Therapeutics Market by Application

  • 5.1 Global Metabolic Disorders Market by Region
  • 5.2 Global Immunologic Disorders Market by Region
  • 5.3 Global Hematological Disorders Market by Region
  • 5.4 Global Cancer Market by Region
  • 5.5 Global Hormonal Disorders Market by Region
  • 5.6 Global Genetic Disorders Market by Region
  • 5.7 Global Others Market by Region

Chapter 6. Global Protein Therapeutics Market by Region

  • 6.1 North America Protein Therapeutics Market
    • 6.1.1 North America Protein Therapeutics Market by Product
      • 6.1.1.1 North America Monoclonal Antibodies Market by Country
      • 6.1.1.2 North America Human Growth Hormone Market by Country
      • 6.1.1.3 North America Fusion Protein Market by Country
      • 6.1.1.4 North America Insulin Market by Country
      • 6.1.1.5 North America Erythropoietin Market by Country
      • 6.1.1.6 North America Interferon Market by Country
      • 6.1.1.7 North America Follicle Stimulating Hormone Market by Country
    • 6.1.2 North America Protein Therapeutics Market by Application
      • 6.1.2.1 North America Metabolic Disorders Market by Country
      • 6.1.2.2 North America Immunologic Disorders Market by Country
      • 6.1.2.3 North America Hematological Disorders Market by Country
      • 6.1.2.4 North America Cancer Market by Country
      • 6.1.2.5 North America Hormonal Disorders Market by Country
      • 6.1.2.6 North America Genetic Disorders Market by Country
      • 6.1.2.7 North America Others Market by Country
    • 6.1.3 North America Protein Therapeutics Market by Country
      • 6.1.3.1 US Protein Therapeutics Market
        • 6.1.3.1.1 US Protein Therapeutics Market by Product
        • 6.1.3.1.2 US Protein Therapeutics Market by Application
      • 6.1.3.2 Canada Protein Therapeutics Market
        • 6.1.3.2.1 Canada Protein Therapeutics Market by Product
        • 6.1.3.2.2 Canada Protein Therapeutics Market by Application
      • 6.1.3.3 Mexico Protein Therapeutics Market
        • 6.1.3.3.1 Mexico Protein Therapeutics Market by Product
        • 6.1.3.3.2 Mexico Protein Therapeutics Market by Application
      • 6.1.3.4 Rest of North America Protein Therapeutics Market
        • 6.1.3.4.1 Rest of North America Protein Therapeutics Market by Product
        • 6.1.3.4.2 Rest of North America Protein Therapeutics Market by Application
  • 6.2 Europe Protein Therapeutics Market
    • 6.2.1 Europe Protein Therapeutics Market by Product
      • 6.2.1.1 Europe Monoclonal Antibodies Market by Country
      • 6.2.1.2 Europe Human Growth Hormone Market by Country
      • 6.2.1.3 Europe Fusion Protein Market by Country
      • 6.2.1.4 Europe Insulin Market by Country
      • 6.2.1.5 Europe Erythropoietin Market by Country
      • 6.2.1.6 Europe Interferon Market by Country
      • 6.2.1.7 Europe Follicle Stimulating Hormone Market by Country
    • 6.2.2 Europe Protein Therapeutics Market by Application
      • 6.2.2.1 Europe Metabolic Disorders Market by Country
      • 6.2.2.2 Europe Immunologic Disorders Market by Country
      • 6.2.2.3 Europe Hematological Disorders Market by Country
      • 6.2.2.4 Europe Cancer Market by Country
      • 6.2.2.5 Europe Hormonal Disorders Market by Country
      • 6.2.2.6 Europe Genetic Disorders Market by Country
      • 6.2.2.7 Europe Others Market by Country
    • 6.2.3 Europe Protein Therapeutics Market by Country
      • 6.2.3.1 Germany Protein Therapeutics Market
        • 6.2.3.1.1 Germany Protein Therapeutics Market by Product
        • 6.2.3.1.2 Germany Protein Therapeutics Market by Application
      • 6.2.3.2 UK Protein Therapeutics Market
        • 6.2.3.2.1 UK Protein Therapeutics Market by Product
        • 6.2.3.2.2 UK Protein Therapeutics Market by Application
      • 6.2.3.3 France Protein Therapeutics Market
        • 6.2.3.3.1 France Protein Therapeutics Market by Product
        • 6.2.3.3.2 France Protein Therapeutics Market by Application
      • 6.2.3.4 Russia Protein Therapeutics Market
        • 6.2.3.4.1 Russia Protein Therapeutics Market by Product
        • 6.2.3.4.2 Russia Protein Therapeutics Market by Application
      • 6.2.3.5 Spain Protein Therapeutics Market
        • 6.2.3.5.1 Spain Protein Therapeutics Market by Product
        • 6.2.3.5.2 Spain Protein Therapeutics Market by Application
      • 6.2.3.6 Italy Protein Therapeutics Market
        • 6.2.3.6.1 Italy Protein Therapeutics Market by Product
        • 6.2.3.6.2 Italy Protein Therapeutics Market by Application
      • 6.2.3.7 Rest of Europe Protein Therapeutics Market
        • 6.2.3.7.1 Rest of Europe Protein Therapeutics Market by Product
        • 6.2.3.7.2 Rest of Europe Protein Therapeutics Market by Application
  • 6.3 Asia Pacific Protein Therapeutics Market
    • 6.3.1 Asia Pacific Protein Therapeutics Market by Product
      • 6.3.1.1 Asia Pacific Monoclonal Antibodies Market by Country
      • 6.3.1.2 Asia Pacific Human Growth Hormone Market by Country
      • 6.3.1.3 Asia Pacific Fusion Protein Market by Country
      • 6.3.1.4 Asia Pacific Insulin Market by Country
      • 6.3.1.5 Asia Pacific Erythropoietin Market by Country
      • 6.3.1.6 Asia Pacific Interferon Market by Country
      • 6.3.1.7 Asia Pacific Follicle Stimulating Hormone Market by Country
    • 6.3.2 Asia Pacific Protein Therapeutics Market by Application
      • 6.3.2.1 Asia Pacific Metabolic Disorders Market by Country
      • 6.3.2.2 Asia Pacific Immunologic Disorders Market by Country
      • 6.3.2.3 Asia Pacific Hematological Disorders Market by Country
      • 6.3.2.4 Asia Pacific Cancer Market by Country
      • 6.3.2.5 Asia Pacific Hormonal Disorders Market by Country
      • 6.3.2.6 Asia Pacific Genetic Disorders Market by Country
      • 6.3.2.7 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Protein Therapeutics Market by Country
      • 6.3.3.1 China Protein Therapeutics Market
        • 6.3.3.1.1 China Protein Therapeutics Market by Product
        • 6.3.3.1.2 China Protein Therapeutics Market by Application
      • 6.3.3.2 Japan Protein Therapeutics Market
        • 6.3.3.2.1 Japan Protein Therapeutics Market by Product
        • 6.3.3.2.2 Japan Protein Therapeutics Market by Application
      • 6.3.3.3 India Protein Therapeutics Market
        • 6.3.3.3.1 India Protein Therapeutics Market by Product
        • 6.3.3.3.2 India Protein Therapeutics Market by Application
      • 6.3.3.4 South Korea Protein Therapeutics Market
        • 6.3.3.4.1 South Korea Protein Therapeutics Market by Product
        • 6.3.3.4.2 South Korea Protein Therapeutics Market by Application
      • 6.3.3.5 Singapore Protein Therapeutics Market
        • 6.3.3.5.1 Singapore Protein Therapeutics Market by Product
        • 6.3.3.5.2 Singapore Protein Therapeutics Market by Application
      • 6.3.3.6 Malaysia Protein Therapeutics Market
        • 6.3.3.6.1 Malaysia Protein Therapeutics Market by Product
        • 6.3.3.6.2 Malaysia Protein Therapeutics Market by Application
      • 6.3.3.7 Rest of Asia Pacific Protein Therapeutics Market
        • 6.3.3.7.1 Rest of Asia Pacific Protein Therapeutics Market by Product
        • 6.3.3.7.2 Rest of Asia Pacific Protein Therapeutics Market by Application
  • 6.4 LAMEA Protein Therapeutics Market
    • 6.4.1 LAMEA Protein Therapeutics Market by Product
      • 6.4.1.1 LAMEA Monoclonal Antibodies Market by Country
      • 6.4.1.2 LAMEA Human Growth Hormone Market by Country
      • 6.4.1.3 LAMEA Fusion Protein Market by Country
      • 6.4.1.4 LAMEA Insulin Market by Country
      • 6.4.1.5 LAMEA Erythropoietin Market by Country
      • 6.4.1.6 LAMEA Interferon Market by Country
      • 6.4.1.7 LAMEA Follicle Stimulating Hormone Market by Country
    • 6.4.2 LAMEA Protein Therapeutics Market by Application
      • 6.4.2.1 LAMEA Metabolic Disorders Market by Country
      • 6.4.2.2 LAMEA Immunologic Disorders Market by Country
      • 6.4.2.3 LAMEA Hematological Disorders Market by Country
      • 6.4.2.4 LAMEA Cancer Market by Country
      • 6.4.2.5 LAMEA Hormonal Disorders Market by Country
      • 6.4.2.6 LAMEA Genetic Disorders Market by Country
      • 6.4.2.7 LAMEA Others Market by Country
    • 6.4.3 LAMEA Protein Therapeutics Market by Country
      • 6.4.3.1 Brazil Protein Therapeutics Market
        • 6.4.3.1.1 Brazil Protein Therapeutics Market by Product
        • 6.4.3.1.2 Brazil Protein Therapeutics Market by Application
      • 6.4.3.2 Argentina Protein Therapeutics Market
        • 6.4.3.2.1 Argentina Protein Therapeutics Market by Product
        • 6.4.3.2.2 Argentina Protein Therapeutics Market by Application
      • 6.4.3.3 UAE Protein Therapeutics Market
        • 6.4.3.3.1 UAE Protein Therapeutics Market by Product
        • 6.4.3.3.2 UAE Protein Therapeutics Market by Application
      • 6.4.3.4 Saudi Arabia Protein Therapeutics Market
        • 6.4.3.4.1 Saudi Arabia Protein Therapeutics Market by Product
        • 6.4.3.4.2 Saudi Arabia Protein Therapeutics Market by Application
      • 6.4.3.5 South Africa Protein Therapeutics Market
        • 6.4.3.5.1 South Africa Protein Therapeutics Market by Product
        • 6.4.3.5.2 South Africa Protein Therapeutics Market by Application
      • 6.4.3.6 Nigeria Protein Therapeutics Market
        • 6.4.3.6.1 Nigeria Protein Therapeutics Market by Product
        • 6.4.3.6.2 Nigeria Protein Therapeutics Market by Application
      • 6.4.3.7 Rest of LAMEA Protein Therapeutics Market
        • 6.4.3.7.1 Rest of LAMEA Protein Therapeutics Market by Product
        • 6.4.3.7.2 Rest of LAMEA Protein Therapeutics Market by Application

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Baxter International, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Approvals and Trials:
      • 7.2.5.2 Acquisition and Mergers:
  • 7.3 Amgen, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Partnerships, Collaborations, and Agreements:
      • 7.3.5.2 Acquisition and Mergers:
  • 7.4 F. Hoffmann-La Roche Ltd.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 Eli Lilly And Company
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expenses
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Partnerships, Collaborations, and Agreements:
      • 7.5.5.2 Acquisition and Mergers:
  • 7.6 Merck & Co., Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Partnerships, Collaborations, and Agreements:
      • 7.6.5.2 Acquisition and Mergers:
  • 7.7 Johnson & Johnson (Janssen Global Services, LLC)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental &Regional Analysis
    • 7.7.4 Research & Development Expenses
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Product Launches and Product Expansions:
      • 7.7.5.2 Acquisition and Mergers:
  • 7.8 Pfizer, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional & Segmental Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Acquisition and Mergers:
  • 7.9 Novo Nordisk A/S
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental & Regional Analysis
    • 7.9.4 Research & Development Expenses
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Partnerships, Collaborations, and Agreements:
  • 7.10. Sanofi S.A.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense